Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€90.60
7D
6.8%
1Y
135.1%
Labiana Health
Market Cap: €24.4m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
LAB
€3.46
7D
3.0%
1Y
38.4%